Skip to main content
Premium Trial:

Request an Annual Quote

Paul Kinnon

Paul Kinnon has been appointed CEO of PredictImmune in Cambridge, UK. He previously held leadership positions at Transgenomic, ZyGem, Life Technologies, Guava Technologies, and Cellomics. Kinnon started his career as an analytical chemist at Smithkline French & Beckman Research, a predecessor of GlaxoSmithKline.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.